iScribeHealth

Generative ambient documentation is real but it was added to an existing business rather than being the business. iScribeHealth was founded in 2015 around a mobile documentation app, speech to text dictation, transcription and human virtual scribe services, all of which it still sells. Strip out the generative layer and a functioning company remains, which is the moat is not the model pattern this index applies to Conveyor AI and Chartnote in this same category. The continuing human scribe offering also puts it in the same structural family as Speke, where AI and human documentation are sold side by side.

Conventional draft and review, with the review step described explicitly as taking seconds before the provider leaves with their last patient. The dictation path is inherently clinician driven, since the provider speaks into a named note section rather than the system deciding placement. Held at B because no acceptance rate, edit burden figure or confidence threshold is published for the ambient path, where the system does choose what goes where.

No accuracy figure, model card, named models or evaluation methodology located. Capability is described in outcome terms, generative AI and speech to text producing documentation in the moment, with the published numbers measuring time and cost saved rather than correctness.

Named customer testimony including an operations executive at a large orthopaedic group, and specific cost figures of 15,000 to 25,000 US dollars saved per provider per year through reduced transcription spend. That figure is more concrete than most claims here because it measures a displaced line item rather than a subjective benefit, but it is vendor reported, dated, and describes cost substitution rather than documentation quality or clinical benefit. No study, controlled evaluation or third party assessment located.

Not assessed. No statement on audio or transcript retention, de identification or training use was located. The question has an extra dimension here because human virtual scribes remain part of the offering, so a buyer should establish whether recordings are accessible to that workforce and where it sits.

Not assessed. No published HIPAA statement or business associate agreement posture was located for this product in this pass.

Not assessed. No named or dated attestation and no trust centre located in this pass.

Not a regulated medical device and none claimed or required for ambient documentation.

Nothing located. No fairness statement, subgroup analysis or accent and dialect disclosure, and no language coverage claimed.

Genuine integration rather than transfer, and unusually granular for a mobile product. Documentation returns directly into the EHR with no copy and paste, and dictated content can be placed into specific note sections including chief complaint, history of present illness, review of systems, physical exam and assessment and plan, which is section level rather than dumping a block of text. Bidirectional flow between app and record is described as a core design property. athenahealth is a named partner and Veradigm is listed. Held at B because the supported EHR list is not enumerated, depth outside athenahealth was not verified, and the product is iOS only.

Not assessed. Cloud service with an iOS mobile client, but no hosting region, residency detail or sub processor information was located.

Thin but not silent. A 14 day free trial with installation support is published, and the vendor commits to deployment within a day, both of which tell a buyer something about cost of adoption. No rate card, tier structure or per provider figure was located, and third party directories describe pricing simply as tailored. Compare the vendors graded A on this axis, which publish the mechanism and the number.

Ambulatory and mobile by design, aimed at clinicians moving through a clinic rather than working at a fixed workstation, with telehealth capability included and orthopaedics among named users. Two real bounds: the product is iOS only, and no specialty count, specialty tuning or language coverage is published, so breadth cannot be compared against the vendors in this category that enumerate both.